CATHERINE EARL: Open Payments
NPI 1942626874 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,048 in 173 payments from 26 companies in 2025. Trend: 2023 $3,026 · 2024 $3,290 · 2025 $3,048
Food & beverage: $3,048
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 24 | $637 |
| Novo Nordisk Inc | 25 | $377 |
| ABBVIE INC. | 29 | $367 |
| Amgen Inc. | 12 | $247 |
| Lilly USA, LLC | 12 | $205 |
| Abbott Laboratories | 12 | $175 |
| Antares Pharma, Inc. | 9 | $170 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $103 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $101 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $90 |
Products named: BREZTRI, VRAYLAR, JARDIANCE, FARXIGA, FREESTYLE LIBRE 3, XYOSTED, Wegovy, AIRSUPRA.
Industry payments across OH — which companies pay providers there.
